Companies
/
Abridge
Healthtech
Abridge is a Pittsburgh-based health technology company whose AI platform listens to patient-clinician conversations and automatically generates structured clinical documentation.
$5.57B
+$164.30
6,943.44%
30 days ago
$2.37
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Sign up with Augment to see the latest market activity.
Abridge was founded in 2018 by Dr. Shiv Rao, a practicing cardiologist, who saw firsthand how much time physicians lose to manual note-taking and how that burden contributes to clinician burnout. The company's core product uses generative AI and speech recognition to listen to a medical visit, either in person or via telehealth, and produce a structured clinical note that maps conversational language into standard medical terminology and formats such as SOAP notes, which clinicians can then review, edit, and sign off on within their existing electronic health record workflow. The goal is to let doctors focus on eye contact and conversation with patients rather than typing during appointments, while still producing clinical documentation for clinician review and approval. Abridge has grown rapidly by partnering directly with large health systems and academic medical centers rather than selling primarily to individual clinicians, integrating with major EHR platforms such as Epic. The company has raised large funding rounds from investors including Lightspeed Venture Partners, General Catalyst, Redpoint Ventures, and IVP, reaching a multi-billion-dollar valuation as ambient clinical documentation has become one of the most closely watched categories in health AI. Abridge competes with other ambient scribe products from companies such as Nuance (owned by Microsoft), Suki, and Ambience Healthcare, and has emphasized clinical-grade accuracy, specialty-specific templates for fields like cardiology and oncology, and structured data extraction that can also support billing and quality-reporting use cases, beyond just producing a readable note for the patient's chart.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
